Meihua Medical Technologies Current Ratio 2021-2024 | MHUA
Meihua Medical Technologies current ratio from 2021 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Meihua Medical Technologies Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-12-31 | $0.14B | $0.03B | 5.26 |
| 2024-06-30 | $0.14B | $0.03B | 4.78 |
| 2023-12-31 | $0.13B | $0.03B | 5.27 |
| 2023-06-30 | $0.13B | $0.02B | 5.70 |
| 2022-12-31 | $0.14B | $0.02B | 5.60 |
| 2022-06-30 | $0.13B | $0.02B | 5.45 |
| 2021-12-31 | $0.10B | $0.03B | 3.34 |
| 2020-12-31 | $0.07B | $0.02B | 3.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.013B | $0.097B |
| Meihua International Medical Technologies Co., Ltd. is a manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries principally in China. The Company manufactures and sells Class I such as eye drops bottle, medicine bottle anal bag etc., Class II and III disposable medical devices such as identification tape, gynecological examination kits, inspection kits, surgical kits, medical brushes, medical dressing, masks, disposable infusion pumps, electronic pumps, puncture kits, etc. under their own brands and also distribute such disposable medical devices sourced from other manufacturers. Meihua International Medical Technologies Co., Ltd. is based in YANGZHOU, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $240.237B | 28.89 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $147.507B | 30.84 |
| EssilorLuxottica (ESLOY) | France | $130.320B | 0.00 |
| Medtronic (MDT) | Ireland | $110.401B | 15.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.194B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.523B | 28.18 |
| Agilent Technologies (A) | United States | $33.417B | 21.78 |
| GE HealthCare Technologies (GEHC) | United States | $32.959B | 15.65 |
| Terumo (TRUMY) | Japan | $27.294B | 35.45 |
| Koninklijke Philips (PHG) | Netherlands | $23.014B | 16.15 |
| Insulet (PODD) | United States | $21.880B | 85.88 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.269B | 11.73 |
| Baxter (BAX) | United States | $15.698B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.073B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.474B | 22.53 |
| Lantheus Holdings (LNTH) | United States | $5.601B | 14.13 |
| Prestige Consumer Healthcare (PBH) | United States | $4.184B | 18.69 |
| Perrigo (PRGO) | Ireland | $3.678B | 9.32 |
| Haemonetics (HAE) | United States | $3.510B | 15.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.221B | 23.75 |
| Envista Holdings (NVST) | United States | $3.210B | 26.68 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| QuidelOrtho (QDEL) | United States | $1.939B | 13.34 |
| LeMaitre Vascular (LMAT) | United States | $1.916B | 42.83 |
| AtriCure (ATRC) | United States | $1.621B | 0.00 |
| Acuren (TIC) | United States | $1.311B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.182B | 12.00 |
| Neogen (NEOG) | United States | $1.070B | 13.69 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.004B | 12.83 |
| Kestra Medical Technologies (KMTS) | United States | $0.906B | 0.00 |
| InMode (INMD) | Israel | $0.870B | 8.76 |
| CeriBell (CBLL) | United States | $0.710B | 0.00 |
| Evolus (EOLS) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.578B | 4.79 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.519B | 0.00 |
| Valneva SE (VALN) | France | $0.477B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.423B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.328B | 12.05 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.10 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.22 |
| Brainsway (BWAY) | Israel | $0.232B | 61.30 |
| Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.229B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.224B | 66.33 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.74 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 14.84 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| MacroGenics (MGNX) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 59.43 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |